The law is not ambiguous on this point
"Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial"
It is a specific form of the broader ingredient, so the terms are closely related but should not be used carelessly when comparing labels, assay bases, and specifications
E.MediatriceH.LinZ.RensingC.YacoutM
compounding pharmacies to meet individual needs
While detecting specific oxidation products requires mass spectrometry (LC-MS), researchers can infer oxidation indirectly: if peptide stored in clear glass vials or exposed to laboratory lighting shows reduced activity in assays compared to foil-wrapped controls, oxidative damage is the likely cause